How Much Is Too Much: Out-Of-Pocket Spending Among Medicare Beneficiaries
Guest authors from AcademyHealth organizational affiliate, Henry J. Kaiser Family Foundation, discuss findings from a recent survey.
Inaugural Health Data Impact Award Honors Work on Patients’ Rights to Access Personal Health Data
Award winner Deven McGraw guided the U.S. Department of Health and Human Services’ efforts to engage technology developers and patients with transparent and effective regulatory frameworks for the use of health data.
Recognizing and Uplifting the Legitimacy of Patient Experts for Better Health Data Tools and Policies
In this final post in a series, ePatient and Security Researcher Andrea Downing highlights where we need to build professional skills and lower barriers for patient experts to be part of a team in health care.
How Telemedicine Can Solve the U.S. Rural Health Crisis
Health Datapalooza speakers Alisahah Cole and Patrice Walker emphasize the need for policymakers, payers, and internet service providers to work together to ensure that rural communities have the opportunity to achieve health equity through high-speed internet access.
States Work to both Adopt and Suspend Medicaid Waiver Demonstrations
Substance Use Disorder continues to be a focus of waiver activity in the states as research provides insights on what’s working and what’s not in Medicaid innovation. Meanwhile, work requirement policies are being both suspended and increased across various states.
Bridging Clinical and Research to Action and Impact
In this fourth post in a series leading up to Health Datapalooza and the National Health Policy Conference, Rasu Shrestha highlights ways clinicians and researchers can move their findings faster into policy, health systems and tech development.
States Experiment with Cross State Comparison to Evaluate Medicaid Waivers for Substance Use Disorder Services
Virginia, Maryland, and West Virginia employed several innovative evaluation strategies to conduct cross-state comparisons for insights around both the impact and implementation of 1115 waivers.
Why We Need Less Data and More Story in the Evidence We Present
In the second of a two-part series, guest author Andy Krackov discusses visualizing your findings in ways that are accessible to a broader audience.
How Clinicians, Patients, and Policymakers can Reduce Harmful Overmedication in Older Americans
Shannon Brownlee and Judith Garber of AcademyHealth organizational affiliate, Lown Institute, highlight key recommendations to eliminate medication overload in older adults.
Embedded Pragmatic Trials for Alzheimer’s Disease: Difficult to Define and Implement, but Desperately Needed
Embedded Pragmatic Trials for Alzheimer’s Disease: Difficult to Define and Implement, but Desperately Needed